The impact of positron emission tomography imaging on the clinical management of patients with epilepsy

References

• Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 114(1), 89–98 (1975).
   PubMed Web of Science ®Google Scholar
• Phelps ME, Hoffman EJ, Coleman RE et al. Tomographic images of blood pool and perfusion in brain and heart. J. Nucl. Med. 17(7), 603–612 (1976).
   PubMedGoogle Scholar
• Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (18F)2-fluoro-2-deoxy-d-glucose: validation of method. Ann. Neurol. 6(5), 371–388 (1979).
   PubMed Web of Science ®Google Scholar
• Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol. 238(1), E69–E82 (1980).
   PubMed Web of Science ®Google Scholar
• Kuhl DE, Engel J Jr, Phelps ME, Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann. Neurol. 8(4), 348–360 (1980).
   PubMed Web of Science ®Google Scholar
• Phelps ME. Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine. Semin. Nucl. Med. 11(1), 32–49 (1981).
   PubMed Web of Science ®Google Scholar
• Engel J Jr, Kuhl DE, Phelps ME, Mazziotta JC. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann. Neurol. 12(6), 510–517 (1982).
   PubMedGoogle Scholar
• Szelies B, Herholz K, Heiss WD et al. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. J. Comput. Assist. Tomogr. 7(6), 946–953 (1983).
   PubMedGoogle Scholar
• Theodore WH, Newmark ME, Sato S et al. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann. Neurol. 14(4), 429–437 (1983).
   PubMedGoogle Scholar
• Engel J Jr, Kuhl DE, Phelps ME, Crandall PH. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann. Neurol. 12(6), 529–537 (1982).
   PubMed Web of Science ®Google Scholar
• Engel J Jr, Kuhl DE, Phelps ME, Rausch R, Nuwer M. Local cerebral metabolism during partial seizures. Neurology 33(4), 400–413 (1983).
   PubMedGoogle Scholar
• Kilpatrick C, O’Brien T, Matkovic Z, Cook M, Kaye A. Preoperative evaluation for temporal lobe surgery. J. Clin. Neurosci. 10(5), 535–539 (2003).
   PubMedGoogle Scholar
• Casse R, Rowe CC, Newton M, Berlangieri SU, Scott AM. Positron emission tomography and epilepsy. Mol. Imaging Biol. 4(5), 338–351 (2002).
   PubMedGoogle Scholar
• DellaBadia J Jr, Bell WL, Keyes JW Jr, Mathews VP, Glazier SS. Assessment and cost comparison of sleep-deprived EEG, MRI and PET in the prediction of surgical treatment for epilepsy. Seizure 11(5), 303–309 (2002).
   PubMedGoogle Scholar
• Uijl SG, Leijten FS, Arends JB, Parra J, van Huffelen AC, Moons KG. The added value of [18F]-fluoro-d-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia 48(11), 2121–2129 (2007).
   PubMedGoogle Scholar
• Labate A, Gambardella A, Aguglia U et al. Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case–control study. Neurology 74(7), 553–557 (2010).
   PubMedGoogle Scholar
• Struck AF, Hall LT, Floberg JM, Perlman SB, Dulli DA. Surgical decision making in temporal lobe epilepsy: a comparison of [(18)F]FDG-PET, MRI, and EEG. Epilepsy Behav. 22(2), 293–297 (2011).
   PubMed Web of Science ®Google Scholar
• Carne RP, O’Brien TJ, Kilpatrick CJ et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain 127(Pt 10), 2276–2285 (2004).
   PubMed Web of Science ®Google Scholar
• Carne RP, O’Brien TJ, Kilpatrick CJ et al. ‘MRI-negative PET-positive’ temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study. BMC Neurol. 7, 16 (2007).
   PubMedGoogle Scholar
• Immonen A, Jutila L, Muraja-Murro A et al. Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy. Epilepsia 51(11), 2260–2269 (2010).
   PubMed Web of Science ®Google Scholar
• Newberg AB, Alavi A, Berlin J, Mozley PD, O’Connor M, Sperling M. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. J. Nucl. Med. 41(12), 1964–1968 (2000).
   PubMed Web of Science ®Google Scholar
• Choi JY, Kim SJ, Hong SB et al. Extratemporal hypometabolism on FDG-PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur. J. Nucl. Med. Mol. Imaging 30(4), 581–587 (2003).
   PubMed Web of Science ®Google Scholar
• Swartz BE, Halgren E, Delgado-Escueta AV et al. Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia 30(5), 547–558 (1989).
   PubMedGoogle Scholar
• Henry TR, Sutherling WW, Engel J Jr et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res. 10(2-3), 174–182 (1991).
   PubMedGoogle Scholar
• da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 38(11), 1198–1208 (1997).
   PubMedGoogle Scholar
• Schlaug G, Antke C, Holthausen H et al. Ictal motor signs and interictal regional cerebral hypometabolism. Neurology 49(2), 341–350 (1997).
   PubMedGoogle Scholar
• Juhász C, Chugani HT. Positron emission tomography: glucose metabolism in extratemporal lobe epilepsy. In: Neuroimaging in Epilepsy. Chugani HT (Ed.). Oxford University Press, NY, USA, 141–155 (2011).
   Google Scholar
• Salamon N, Kung J, Shaw SJ et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology 71(20), 1594–1601 (2008).
   PubMed Web of Science ®Google Scholar
• Lerner JT, Salamon N, Hauptman JS et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 50(6), 1310–1335 (2009).
   PubMed Web of Science ®Google Scholar
• Mathern GW. Challenges in the surgical treatment of epilepsy patients with cortical dysplasia. Epilepsia (50 Suppl. 9), 45–50 (2009).
   PubMedGoogle Scholar
• Palmini A, Najm I, Avanzini G et al. Terminology and classification of the cortical dysplasias. Neurology 62(6 Suppl. 3), S2–S8 (2004).
   PubMed Web of Science ®Google Scholar
• Kim YH, Kang HC, Kim DS et al. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia 52(4), 722–727 (2011).
   PubMed Web of Science ®Google Scholar
• Seo JH, Holland K, Rose D et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology 76(1), 41–48 (2011).
   PubMed Web of Science ®Google Scholar
• Kumar A, Juhász C, Asano E, Sood S, Muzik O, Chugani HT. Objective detection of epileptic foci by 18F-FDG-PET in children undergoing epilepsy surgery. J. Nucl. Med. 51(12), 1901–1907 (2010).
   PubMed Web of Science ®Google Scholar
• Chassoux F, Rodrigo S, Semah F et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 75(24), 2168–2175 (2010).
   PubMed Web of Science ®Google Scholar
• Juhász C, Chugani DC, Muzik O et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 55(6), 825–835 (2000).
   PubMedGoogle Scholar
• Juhász C, Chugani DC, Muzik O et al. Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? Ann. Neurol. 48(1), 88–96 (2000).
   PubMedGoogle Scholar
• Alkonyi B, Juhász C, Muzik O et al. Quantitative brain surface mapping of an electrophysiologic/metabolic mismatch in human neocortical epilepsy. Epilepsy Res. 87(1), 77–87 (2009).
   PubMedGoogle Scholar
• Prince DA, Wilder BJ. Control mechanisms in cortical epileptogenic foci. ‘Surround’ inhibition. Arch. Neurol. 16(2), 194–202 (1967).
   PubMedGoogle Scholar
• Collins RC. Use of cortical circuits during focal penicillin seizures: an autoradiographic study with [14C]deoxyglucose. Brain Res. 150(3), 487–501 (1978).
   PubMedGoogle Scholar
• Bruehl C, Witte OW. Cellular activity underlying altered brain metabolism during focal epileptic activity. Ann. Neurol. 38(3), 414–420 (1995).
   PubMed Web of Science ®Google Scholar
• Witte OW, Bruehl C, Schlaug G et al. Dynamic changes of focal hypometabolism in relation to epileptic activity. J. Neurol. Sci. 124(2), 188–197 (1994).
   PubMedGoogle Scholar
• Nelissen N, Van Paesschen W, Baete K et al. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. Neuroimage 32(2), 684–695 (2006).
   PubMed Web of Science ®Google Scholar
• Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann. Neurol. 27(4), 406–413 (1990).
   PubMed Web of Science ®Google Scholar
• Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J. Child Neurol. 11(1), 44–48 (1996).
   PubMedGoogle Scholar
• Chugani HT, Asano E, Sood S. Infantile spasms: who are the ideal surgical candidates? Epilepsia 51(Suppl. 1), 94–96 (2010).
   PubMed Web of Science ®Google Scholar
• Asarnow RF, LoPresti C, Guthrie D et al. Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev. Med. Child Neurol. 39(7), 430–440 (1997).
   PubMed Web of Science ®Google Scholar
• Jonas R, Asarnow RF, LoPresti C et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology 64(4), 746–750 (2005).
   PubMed Web of Science ®Google Scholar
• Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2(8616), 863–866 (1988).
   PubMedGoogle Scholar
• Henry TR, Frey KA, Sackellares JC et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 43(10), 1998–2006 (1993).
   PubMed Web of Science ®Google Scholar
• Savic I, Ingvar M, Stone-Elander S. Comparison of 11C -flumazenil and 18F-FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 56, 615–621 (1993).
   PubMed Web of Science ®Google Scholar
• Koepp MJ, Richardson MP, Brooks DJ et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 119(Pt 5), 1677–1687 (1996).
   PubMed Web of Science ®Google Scholar
• Szelies B, Weber-Luxenburger G, Pawlik G et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 3(2), 109–118 (1996).
   PubMed Web of Science ®Google Scholar
• Ryvlin P, Bouvard S, Le Bars D et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 121(Pt 11), 2067–2081 (1998).
   PubMedGoogle Scholar
• Juhász C, Nagy F, Muzik O, Watson C, Shah J, Chugani HT. [11C]Flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 40(5), 566–574 (1999).
   PubMedGoogle Scholar
• Lamusuo S, Pitkänen A, Jutila L et al. [11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 54(12), 2252–2260 (2000).
   PubMedGoogle Scholar
• Szelies B, Weber-Luxenburger G, Mielke R et al. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry. Eur. J. Neurol. 7(4), 393–400 (2000).
   PubMedGoogle Scholar
• Koepp MJ, Hammers A, Labbé C, Woermann FG, Brooks DJ, Duncan JS. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 54(2), 332–339 (2000).
   PubMedGoogle Scholar
• Hammers A, Koepp MJ, Hurlemann R et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 125(Pt 10), 2257–2271 (2002).
   PubMedGoogle Scholar
• Ryvlin P, Bouvard S, Le Bars D, Mauguière F. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 53(8), 1882–1885 (1999).
   PubMedGoogle Scholar
• Bouvard S, Costes N, Bonnefoi F et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain 128(Pt 6), 1330–1343 (2005).
   PubMedGoogle Scholar
• Savic I, Thorell JO, Roland P. [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 36(12), 1225–1232 (1995).
   PubMedGoogle Scholar
• Muzik O, da Silva EA, Juhasz C et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 54(1), 171–179 (2000).
   PubMedGoogle Scholar
• Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, Duncan JS. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 126(Pt 6), 1300–1318 (2003).
   PubMed Web of Science ®Google Scholar
• Hammers A, Koepp MJ, Brooks DJ, Duncan JS. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia 46(6), 944–948 (2005).
   PubMed Web of Science ®Google Scholar
• Koepp MJ. [11C]Flumazenil positron emission tomography. In: Neuroimaging in Epilepsy. Chugani HT (Ed.). Oxford University Press, NY, USA, 174–185 (2011).
   Google Scholar
• Juhász C, Chugani DC, Muzik O et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 56(12), 1650–1658 (2001).
   PubMedGoogle Scholar
• Juhász C, Asano E, Shah A et al. Focal decreases of cortical GABAA receptor binding remote from the primary seizure focus: what do they indicate? Epilepsia 50(2), 240–250 (2009).
   PubMed Web of Science ®Google Scholar
• Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 37(3), 236–244 (1996).
   PubMedGoogle Scholar
• Savic I, Blomqvist G, Halldin C, Litton JE, Gulyas B. Regional increases in [11C]flumazenil binding after epilepsy surgery. Acta Neurol. Scand. 97(5), 279–286 (1998).
   PubMedGoogle Scholar
• Gründer G, Siessmeier T, Lange-Asschenfeldt C et al. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. Eur. J. Nucl. Med. 28(10), 1463–1470 (2001).
   PubMedGoogle Scholar
• Levêque P, Sanabria-Bohorquez S, Bol A et al. Quantification of human brain benzodiazepine receptors using [18F]fluoroethylflumazenil: a first report in volunteers and epileptic patients. Eur. J. Nucl. Med. Mol. Imaging 30(12), 1630–1636 (2003).
   PubMedGoogle Scholar
• Massaweh G, Schirrmacher E, la Fougere C et al. Improved work-up procedure for the production of [18F]flumazenil and first results of its use with a high-resolution research tomograph in human stroke. Nucl. Med. Biol. 36(7), 721–727 (2009).
   PubMedGoogle Scholar
• la Fougère C, Grant S, Kostikov A et al. Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. Neuroimage 56(3), 951–960 (2011).
   PubMedGoogle Scholar
• Diksic M, Tohyama Y, Takada A. Brain net unidirectional uptake of alpha-[14C]methyl-l-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp. Neurochem. Res. 25(12), 1537–1546 (2000).
   PubMedGoogle Scholar
• Trottier S, Evrard B, Vignal JP, Scarabin JM, Chauvel P. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res. 25(2), 79–106 (1996).
   PubMed Web of Science ®Google Scholar
• Chugani DC, Chugani HT, Muzik O et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-l-tryptophan positron emission tomography. Ann. Neurol. 44(6), 858–866 (1998).
   PubMed Web of Science ®Google Scholar
• Asano E, Chugani DC, Muzik O et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54(10), 1976–1984 (2000).
   PubMed Web of Science ®Google Scholar
• Fedi M, Reutens DC, Andermann F et al. alpha-[11C]-Methyl-l-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res. 52(3), 203–213 (2003).
   PubMedGoogle Scholar
• Kagawa K, Chugani DC, Asano E et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l-tryptophan positron emission tomography (PET). J. Child Neurol. 20(5), 429–438 (2005).
   PubMed Web of Science ®Google Scholar
• Fedi M, Reutens D, Okazawa H et al. Localizing value of alpha-methyl-l-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 57(9), 1629–1636 (2001).
   PubMedGoogle Scholar
• Juhász C, Chugani DC, Muzik O et al. Alpha-methyl-l-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60(6), 960–968 (2003).
   PubMedGoogle Scholar
• Wakamoto H, Chugani DC, Juhász C, Muzik O, Kupsky WJ, Chugani HT. Alpha-methyl-l-tryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr. Neurol. 39(3), 181–188 (2008).
   PubMedGoogle Scholar
• Alkonyi B, Mittal S, Zitron I et al. Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors. J. Neurooncol. 107(2), 365–372 (2012).
   PubMedGoogle Scholar
• Chugani HT, Kumar A, Kupsky W, Asano E, Sood S, Juhász C. Clinical and histopathologic correlates of 11C-alpha-methyl-l-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia 52(9), 1692–1698 (2011).
   PubMed Web of Science ®Google Scholar
• Chugani DC, Muzik O. Alpha[C-11]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J. Cereb. Blood Flow Metab. 20(1), 2–9 (2000).
   PubMed Web of Science ®Google Scholar
• Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8(20), 1–27 (2006).
   PubMedGoogle Scholar
• Ravizza T, Boer K, Redeker S et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 24(1), 128–143 (2006).
   PubMed Web of Science ®Google Scholar
• Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 22(6), 797–803 (2008).
   PubMed Web of Science ®Google Scholar
• Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J. Neuropathol. Exp. Neurol. 69(8), 838–849 (2010).
   PubMedGoogle Scholar
• Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat. Rev. Neurol. 7(1), 31–40 (2011).
   PubMed Web of Science ®Google Scholar
• Banati RB, Goerres GW, Myers R et al. [11C]®-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology 53(9), 2199–2203 (1999).
   PubMedGoogle Scholar
• Kumar A, Chugani HT, Luat A, Asano E, Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr. Neurol. 38(6), 439–442 (2008).
   PubMedGoogle Scholar
• Boer K, Spliet WG, van Rijen PC, Redeker S, Troost D, Aronica E. Evidence of activated microglia in focal cortical dysplasia. J. Neuroimmunol. 173(1-2), 188–195 (2006).
   PubMed Web of Science ®Google Scholar
• Choi J, Nordli DR Jr, Alden TD et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflammation 6, 38 (2009).
   PubMed Web of Science ®Google Scholar
• Butler T, Ichise M, Teich AF et al. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J. Neuroimaging doi:10.1111/j.1552-6569.2010.00572.x (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Bien CG, Scheffer IE. Autoantibodies and epilepsy. Epilepsia 52(Suppl. 3), 18–22 (2011).
   PubMedGoogle Scholar
• Buck JR, McKinley ET, Hight MR et al. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. J. Nucl. Med. 52(1), 107–114 (2011).
   PubMed Web of Science ®Google Scholar
• Takano A, Gulyás B, Varrone A et al. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study. Eur. J. Nucl. Med. Mol. Imaging 38(11), 2058–2065 (2011).
   PubMedGoogle Scholar
• Wada Y, Nakamura M, Hasegawa H, Yamaguchi N. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci. Lett. 141(1), 21–24 (1992).
   PubMedGoogle Scholar
• Gariboldi M, Tutka P, Samanin R, Vezzani A. Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br. J. Pharmacol. 119(5), 813–818 (1996).
   PubMedGoogle Scholar
• Toczek MT, Carson RE, Lang L et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60(5), 749–756 (2003).
   PubMedGoogle Scholar
• Savic I, Lindström P, Gulyás B, Halldin C, Andrée B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62(8), 1343–1351 (2004).
   PubMedGoogle Scholar
• Merlet I, Ostrowsky K, Costes N et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 127(Pt 4), 900–913 (2004).
   PubMedGoogle Scholar
• Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguière F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 131(Pt 10), 2751–2764 (2008).
   PubMedGoogle Scholar
• Liew CJ, Lim YM, Bonwetsch R et al. 18F-FCWAY and 18F-FDG-PET in MRI-negative temporal lobe epilepsy. Epilepsia 50(2), 234–239 (2009).
   PubMedGoogle Scholar
• Theodore WH, Hasler G, Giovacchini G et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48(8), 1526–1530 (2007).
   PubMed Web of Science ®Google Scholar
• Lothe A, Didelot A, Hammers A et al. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131(Pt 10), 2765–2782 (2008).
   PubMedGoogle Scholar
• Theodore WH, Wiggs EA, Martinez AR et al. Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy. Epilepsia 53(1), 129–133 (2012).
   PubMedGoogle Scholar
• Knowlton RC, Elgavish RA, Limdi N et al. Functional imaging: I. Relative predictive value of intracranial electroencephalography. Ann. Neurol. 64(1), 25–34 (2008).
   PubMed Web of Science ®Google Scholar
• O’Brien TJ, Miles K, Ware R, Cook MJ, Binns DS, Hicks RJ. The cost-effective use of 18F-FDG-PET in the presurgical evaluation of medically refractory focal epilepsy. J. Nucl. Med. 49(6), 931–937 (2008).
   PubMedGoogle Scholar
• Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann. Neurol. 58(4), 525–532 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JT, Bai SJ, Choi KO et al. Comparison of various imaging modalities in localization of epileptogenic lesion using epilepsy surgery outcome in pediatric patients. Seizure 18(7), 504–510 (2009).
   PubMedGoogle Scholar
• Goffin K, Van Paesschen W, Dupont P et al. Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI. Eur. J. Nucl. Med. Mol. Imaging 37(6), 1148–1155 (2010).
   PubMedGoogle Scholar
• Baete K, Nuyts J, Van Laere K et al. Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage 23(1), 305–317 (2004).
   PubMedGoogle Scholar
• Blümcke I, Thom M, Aronica E et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52(1), 158–174 (2011).
   PubMed Web of Science ®Google Scholar
• Pitkänen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 10(2), 173–186 (2011).
   PubMed Web of Science ®Google Scholar
• Laufs H, Richardson MP, Salek-Haddadi A et al. Converging PET and fMRI evidence for a common area involved in human focal epilepsies. Neurology 77(9), 904–910 (2011).
   PubMedGoogle Scholar
• Fedi M, Berkovic SF, Marini C, Mulligan R, Tochon-Danguy H, Reutens DC. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage 32(3), 995–1000 (2006).
   PubMedGoogle Scholar